Viveve Medical
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HOLMES BENJAMIN L director
Common Stock 20,000 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 29,500 N/A N/A
Purchase
HOLMES BENJAMIN L director
Common Stock 20,000 N/A N/A
Purchase
KAYNE FRED other: Shareholder
common stock 341,500 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 5,000 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 4,000 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 20,000 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 20,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 4,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 2,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 2,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 1,000 N/A N/A
Sale
LUPPI KENNETH J officer: VP, Operations
Common Stock 4,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 5,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 10,000 N/A N/A
Sale
RUDKO ROBERT I director, officer: Chief Scient..
Common Stock 5,000 N/A N/A
Purchase
TAUSCHER MARK R director, officer: President & ..
Common Stock 23,930 N/A N/A

Showing 50 to 67 of 67 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.